Ind-Swift Faces Challenges Amidst Broader Pharmaceutical Sector Trends
Ind-Swift, a microcap in the Pharmaceuticals & Drugs sector, is nearing a 52-week low, with its stock significantly underperforming the market. It has consistently traded below key moving averages and has seen a notable decline over the past year, contrasting with broader market gains.
Ind-Swift, a microcap player in the Pharmaceuticals & Drugs industry, has experienced significant activity today, with its stock price nearing a 52-week low. As of February 19, 2025, the stock is just 3.28% away from its low of Rs 13.25. The company's performance has been notably weak, underperforming its sector by 1.41% today.In terms of moving averages, Ind-Swift is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a consistent downward trend over various time frames. Over the past year, the stock has declined by 24.68%, contrasting sharply with the Sensex, which has gained 4.87% during the same period.
These metrics highlight the challenges faced by Ind-Swift in the current market environment, reflecting broader trends within the pharmaceutical sector. Investors and market watchers will be keen to observe how the company navigates these difficulties moving forward.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
